U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta
(Reuters) – The U.S. Food and Drug Administration on Thursday granted Mylan NV tentative approval for its generic version of…
FDA says Mylan’s EpiPen is in shortage
(Reuters) – U.S. regulators said on Wednesday that Mylan NV’s (MYL.O) EpiPen products are in shortage, due to manufacturing delays…
FDA says manufacturing delays are constraining EpiPen supply
NEW YORK (Reuters) – The U.S. Food and Drug Administration added Mylan NV’s (MYL.O) EpiPen to its list of drugs…
Canada seeks U.S. help to solve EpiPen shortage
TORONTO (Reuters) – Canada said on Tuesday it is working with the U.S. Food and Drug Administration to access supplies…